Simmons First Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Simmons First Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2.74M	Buy	+41,809	New	+$2.58M	0.31%	63

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Simmons First Trust's TEVA Position: Q4 2015 in Review

Simmons First Trust opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2015: 41,809 shares worth $2.74M. The stake represents 0.31% of the portfolio and ranks #63 among its holdings.

876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Simmons First Trust held 41,809 shares of Teva Pharmaceuticals worth $2.74M as of Q4 2015.
Teva Pharmaceuticals was a new Simmons First Trust position in Q4 2015.
Teva Pharmaceuticals made up 0.31% of Simmons First Trust's portfolio in Q4 2015, its #63 holding.
876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Simmons First Trust's 13F filing for Q4 2015, filed 1 Feb 2016.